The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-JD Sports leads FTSE 100 higher, rate cut hopes support

Tue, 10th Sep 2019 09:46

* FTSE 100 up 0.4%, FTSE 250 up 0.3%

* JD Sports hits life high after profit rise

* Galliford jumps on deal talks

* 888 skids as earnings hit by higher tax, Brexit-related
expenses
(Adds new items, analyst comments, updates to closing prices)

By Muvija M and Shashwat Awasthi

Sept 10 (Reuters) - London's FTSE 100 overcame early losses
to close higher on Tuesday as hopes of imminent interest rate
cuts from major central banks buoyed sentiment, while JD Sports
jumped to an all-time high on upbeat results.

The blue-chip index added 0.4%, with JD Sports
gaining 8.8% after its gym clothing and premium-branded
fashion helped it post higher profit and offset UK retail sector
gloom.

The FTSE 250 rose 0.3%, helped in part by a nearly
13% surge in Cairn Energy as strong half-year results
led to a production target upgrade.

In a sign of ongoing rotation, investors dumped defensive
shares and bought stocks of sectors that have underperformed
this year, helping an index of banks climb 2.4% for
its best day since January.

Shares of Lloyds and Barclays rose 4.3%
and 4.9%, respectively, while healthcare stocks GlaxoSmithKline
and AstraZeneca shed more than 2% each.

UK markets also looked past disappointing data from China
overnight that had added to fears of a global recession.

Speculation that the European Central Bank will cut interest
rates this week and that the U.S. Federal Reserve will follow
suit later this month in the face of slowing economic growth
helped stoke some risk appetite.

"Seeing as the ECB are tipped to go down the path of an
interest rate cut, stocks are likely to be buoyant between now
and the announcement," CMC Markets analyst David Madden said.

Oil heavyweights Shell and BP were the
biggest boosts to the main index as they tracked a rise in crude
prices on hopes that OPEC and other oil-producing countries may
agree to extend output cuts to prop up prices.

Mid-cap builder Galliford Try advanced 8% after it
restarted preliminary talks to sell its residential housing
businesses to Bovis Homes.

Bovis, whose shares dropped 3.5%, nudged up its proposed
offer and included a cash element, which Markets.com analyst
Neil Wilson said would be "a welcome injection for the newly
reorganised Galliford construction division."

Among small-caps, online gambling firm 888 Holdings
slumped 8.6%, its worst day in almost a year, after results
showed a hit to earnings from a rise in online gaming taxes and
administrative expenses due to Brexit preparations.
(Reporting by Muvija M in Bengaluru; Editing by Arun Koyyur and
Dan Grebler)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.